Although it could be argued the reduction in JE incidence is lower in low/moderate risk compared to high risk districts following vaccination [22, 40], we nevertheless recommend consideration of further JE vaccination campaigns in areas of low/moderate JE incidence and in any district where JEV IgM is detected. The gene discussed is CD40LG; the disease is Japanese encephalitis.